Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Home » Anti-Aging

World's First Anti-aging drug? Fact or another Fiction?

By kcrofton at Nov. 30, 2015, 1:18 p.m., 14410 hits

A miracle drug? One wonders…

Here is news from London - via The Telegraph:

“The world’s first anti-aging drug will be tested on humans next year in trials that could result in people being able to live healthily well into their 120s.
…researchers have already proven that the diabetes drug metformin extends the life of animals, and the Food and Drug Administration in the U.S. has now given the go-ahead for a trial to see if the same effects can be replicated in humans.
… Scientists now believe it is possible to stop people growing old as quickly and consign diseases such as Alzheimer’s and Parkinson’s to history.” Sarah Knapton, The Telegraph.

If true, this would be very good news as if you have read any of my posts, or my book, A Wellness Guide for The Digital Age, you will already be aware of the growing concerns of brain health in this increasingly high-tech world.

There is evidence that the RR - wireless microwave - radiation from cell tower antennas, WiFi, mobile phones and all wirelessly-connected devices such as iPads, causes leakage of the blood-brain barrier and damage to the brain.

Combine this with evidence of damage to DNA and DNA repair you have a clear picture of why so many international health authorities and agencies are calling for caution with wireless radiation exposure.

A ‘miracle’ anti-aging drug is always welcome - if it is effective and without adverse side effects. That would be a miracle. The report of this one seems dubious.

However, there are more details on the public health challenges of the digital age, healthy aging and how to reduce your risks while enjoying the benefits of technology at: www.SaferTechSolutions.org



— Last Edited by Kerry Crofton, PhD at 2015-11-30 13:18:48 —

— Last Edited by Kerry Crofton, PhD at 2015-12-01 07:45:08 —

 
No Reply